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Introduction
The ABCC11 gene product (MRP8) is a member of
multidrug resistance protein (MRP) family of ATP-binding
cassette transporters. MRP8 functions as a transmembrane
efflux pump and is able to transport a large range of diverse
substrates, including cyclic nucleotides, monoanionic bile
acids, and steroid sulfates.1-2 The ABCC11 transcript is ex-
pressed in various tissues3-7 and, of particular interest, in
apocrine glands in the external auditory canal, axillary re-
gion, and the breast. It is also highly expressed in breast
cancer cells.5
We have recently revealed the physiological function of
MRP8,8 showing that a single nucleotide polymorphism (SNP)
at nucleotide 538 (c.538G/A, rs17822931) of ABCC11 de-
termines the human earwax type in a way that individuals
with GG and GA genotypes have wet earwax, and AA
homozygotes have dry earwax. A variant form of MRP8
protein (MRP8-180R, c.538A results in Arg180 instead of
Gly180) has deficient transport activity compared to the wild
type (MRP8-180G, c.538G results in Gly180).8 Indeed, func-
tions of two other apocrine glands, i.e., axillary and mam-
mary glands, are related to the genotype at rs178229316,9-10
as well. Axillary osmidrosis, a condition with excessive
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The rs17822931 SNP of the human ABCC11 gene determines earwax types, and is also associated with some functions of
apocrine glands, including the mammary gland. Nevertheless, whether the ABCC11 polymorphism is correlated with estrogen
receptor (ER) status of breast cancer (BC) remains unclear. To investigate the correlation between rs17822931 and BC, we
screened the genotypes in a total of 276 and 295 histological BC samples collected from Japanese and Ukrainian BC patients,
and 269 and 264 ethnically-matched healthy individuals, respectively, using TaqManTM PCR. Genotype frequencies at
rs178229131 in Japanese and Ukrainian BC patients were not significantly different from those in their respective control
populations. Consistently, no correlation between rs178229131 and the susceptibility to BC was found. The AA genotype,
which corresponds to dry earwax, occurred less frequently in ER -negative BC in Japanese [odds ratio, 0.48; 95% confidential
interval, 0.29-0.80] but not in Ukrainian patients although a similar correlation was weakly observed. Our results indicate that
the rs178229131-A allele may be important in reducing the risk of ER -negative BC development.
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axillary odor, has been demonstrated to strongly associate
with wet earwax9, and similarly, decreased volume of colostrum
24 hrs after delivery was more frequently seen in parturient
women with dry-type earwax10.
Despite evident connection between the type of earwax
and apocrine gland functioning, the role of rs17822931 in
susceptibility to breast cancer (BC) remains controversial.11-13
Two most recent genotype analyses also showed discrepant
results.14,15 Ota et al.14 claimed that the wild-type allele,
rs17822931-G, is associated with BC in the Japanese, irre-
spective of the estrogen receptor (ER) status and other
clinicopathological features. However, Beesley et al.15 found
no evidence for association of rs17822931 with BC in
Caucasian women. Therefore, additional genotyping stud-
ies are essential to shed light on an existing disagreement.
Whether the ABCC11 polymorphism correlates with the ER
status of breast cancer cells, an important factor in cancer
prognosis and therapy, also remains unclear.
Here, we analyzed genotypes at rs17822931 in patients
with ER -positive (ER +) and ER -negative (ER -) BC,
and compared genotype frequencies between cancer patients
and control females in the Japanese and Ukrainian populations.
Patients and Methods
Samples
The study protocol was approved by Committee for Ethical
Issues on Human Genome and Gene Analysis of Health
Sciences University of Hokkaido. Of a total of 480 breast
cancer (BC) surgical specimens used for analysis, 185 BC cases
from Nagasaki prefecture were provided by the Department
of Pathology, Atomic Bomb Disease Institute, Nagasaki
University, Japan, 121 Ukrainian cases by Regional Diagnostic
Center, Dnepropetrovsk, Ukraine, and 174 by the Department
of Genetic Diagnostics, State Institute of Genetic and Regen-
erative Medicine, Kiev, Ukraine. Information on ER status
of BC samples (positive/negative) was obtained from these
institutions. ER was evaluated by H-score immunohistochemistry.
The samples were stored as paraffin blocks in pathological
archives of the institutions. Several 5- m sections of each
sample mounted on microscope slides were provided for the
current study. Albeit not sampled in this study, genotype data
for another series of 91 BC patients from Nagasaki prefec-
ture with known ER status were provided by Department
of Human Genetics of Nagasaki University Graduate School
of Biomedical Science.
As control samples from the Ukrainian population,
fingernail clippings were collected from 177 Ukrainian vol-
unteers after obtaining informed consent. Also, 45 surgical
specimens from patients with diseases other than BC were
provided by Regional Diagnostic Center, Dnepropetrovsk,
Ukraine. As controls from the Japanese population (Nagasaki
prefecture), 100 surgical specimens from patients with dis-
eases other than BC were provided by the Department of
Pathology, Atomic Bomb Disease Institute, Nagasaki University,
Japan. In addition, our previous genotyping data for 42
Ukrainian and 169 Japanese controls from the same dis-
trict/prefecture were available.8, 16
Cumulatively, the study included 276 Japanese and 295
Ukrainian BC patients aged 55.8±11.4 years (28-88 years
old, range) and 52.3±11.1 years (21-87 years old, range) at
diagnosis, respectively, and 269 Japanese and 264 Ukrainian
controls aged 58.2±12.3 (17-90 years old, range) and 55.2±
9.6 years (19-82 years old, range) at sampling, respectively.
DNA extraction and genotyping
DNA was extracted from paraffin-embedded BC samples
using DEXPAT reagent (TaKaRa Bio Inc., Otsu, Japan) ac-
cording to the supplier's protocol. DNA was further precipi-
tated with EtOH, and purified DNA (2 l) was used as a
template in genotyping reactions.
After washing with PBS/0.5% SDS solution and with
70% EtOH, the nail clippings from control individuals were
frozen in liquid nitrogen and crushed into fine powder with
Multi-beads Shocker (Yasui Kikai, Osaka, Japan). The nail
powder was treated with ISOHAIR (Nippon Gene, Tokyo,
Japan) at 55°C overnight. DNA was extracted with phenol/
chloroform, precipitated with EtOH, incubated in 200 l
1xTE/0.5%SDS containing 3 l of 10mg/ml proteinase K
at 55°C overnight and then again subjected to phenol/chlo-
roform extraction and EtOH-precipitation.
BC and control samples were genotyped by TaqManTM
PCR using hydrolyzing probes and a set of amplifying
primers, according to our recent work.16 Reaction was per-
formed in the TaqMan® Universal PCR Master Mix (Applied
Biosystems, Foster City, CA, USA), with the following
thermal cycling conditions: after initial incubation at 50°C
for 2 min, followed by incubation at 95°C for 10 min, PCR
was cycled 50 times at 92°C for 15 sec, and at 60°C for 1
min. PCR was run on Rotor-Gene Q (QIAGEN, Tokyo,
Japan). Four replicas of each sample were processed in one
reaction. Genotypes were assessed by automated allelic dis-
crimination analysis, and by comparison with external con-
trols with known genotypes.
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Statistical analysis
Association of the rs17822931 with breast cancer risk was
estimated using multivariate logistic regression analysis for
the co-dominant, log-additive, dominant and recessive
models, and odds ratios (OR) and 95% confidence intervals
(CI) were calculated. Similar analysis was done to assess
correlation between the polymorphism and the ER status
of BC. A conventional level of significance of P<0.05 was
chosen. Statistical analyses were performed using an on-
line software package.17
The study had a power of >83% at less than 0.05 level of
type I error to detect on OR of 1.75 in Japanese cases, tak-
ing into account the wet phenotype frequency of 23% among
Japanese.16 In Ukrainian cases, the study had a power of >80%
to detect per-allele OR of 1.81 with the A allele frequency
of 0.163, however less power to detect recessive effects.
Results
The distribution of genotypes at rs17822931 among cases
and controls, and in patients grouped according to ER
status is shown in Table 1. The A allele frequencies corre-
spond to values of 0.125 and 0.890 represented in the NCBI
SNP database for European and Japanese groups, respec-
tively (build 132, September 2010).
We compared genotype (GG, GA, and AA), and earwax
type (wet or dry) frequencies in BC patients with respective
control values. As shown in Table 2, there was no evidence
that would reject the null hypothesis of rs17822931 not
being correlated with BC risk.
BC samples with known ER status (295 Ukrainian and
250 Japanese BC cases) were included into the analysis of
association between c.538G/A, rs17822931 and two BC
subtypes (i.e., ER + and ER -). The results are summa-
rized in Table 3.
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Table 1. Genotypes at rs17822931 and the A allele frequencies

































































aBC, breast cancer bER, estrogen receptor *Chi-square test
Table 2. Results of the logistic regression analyses of rs17822931
association with breast cancer risk in Japanese (Nagasaki prefecture)
and Ukrainian populations according to different inheritance models






Risk per A alleleb
GA + AA vs GGc
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GA + AA vs GG





















aCo-dominant model of inheritance. bLog-additive model of inheritance.
cDominant model of inheritance. dRecessive model of inheritance.
*Adjusted for age
Table 3. Association of genotypes at rs17822931 with breast cancer
(BC) subtypes (i.e., estrogen receptor positive (ER+) and ER nega-
tive (ER-)) in 250 Japanese and 295 Ukrainian cases. P<0.05 in bold
Population,
genotype
ER+ BC versus controls ER- BC versus controls





Risk per A alleleb
GA + AA vs GGc





Risk per A allele
GA + AA vs GG









































aCo-dominant model of inheritance. bLog-additive model of inheritance.
cDominant model of inheritance. dRecessive model of inheritance.
*Adjusted for age
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The dry-type earwax (AA genotype) was less frequently
seen in ER - BC in Japanese population (OR=0.48; 95%
CI, 0.29-0.80, P=0.005). Hence, rs17822931-A may be as-
sociated with a decreased risk of the ER - BC development
(OR=0.54; 95% CI, 0.35-0.85, P=0.008). In Ukrainians, a
similar correlation was observed, however it was not statis-
tically significant given a very low frequency of "AA"
homozygotes in the population.
Discussion
The present study was conducted to test whether the
ABCC11 polymorphism correlated with a susceptibility to
BC in humans. The proposed hypothesis that earwax type
may associate with BC risk is based on the common origin
of ceruminous and mammary glands.7, 13 The ABCC11 gene
product, MRP8 (multidrug resistance protein), together
with other ABC transporters, showed an increased expres-
sion in BC patients who responded poorly to neoadjuvant
chemotherapy in one study.18 Such a resistance to anticancer
treatments is likely attributed to MRP8 ability to transport
5-fluoro-2'-deoxyuridine 5'-monophosphate (FdUMP), an active
metabolite of the chemotherapy agent, 5-fluorouracil (5-FU).19
Moreover, because MRP8 can transport glucuronidated and
sulfated steroids,1 the protein may play a role in regulatory
cell responses to sex steroids in breast tissues, particularly
to estrogens. Together, these MRP8 characteristics support
the notion that the ABCC11 SNP genotypes may be in-
volved in mammary gland carcinogenesis.
We found that ABCC11 genotype rs17822931 and ear-
wax phenotype frequencies in BC patients did not signifi-
cantly differ from those in the controls in allele-A rich
Japanese, or allele-G rich Ukrainian populations (Table 2).
The observed lack of association between rs17822931 and
BC in Ukrainian women is consistent with the observation
of Beesley et al.15 who found no association in Caucasian
patients. By contrast, in a recent report, a positive correla-
tion of the allele-G with BC risk was detected in 270 sam-
ples collected in Yokohama district, neighboring the Tokyo
metropolitan area, when compared with 273 control indi-
viduals.14 Taking into consideration the stratification of
Japanese map with regard to rs17822931-A frequency,16 the
control individuals should be chosen with particular cau-
tion, as demonstrated in this study. To evaluate the associa-
tion between ABCC11 polymorphism and BC risk nation-
wide, an increased cohort of patients proportionally from
all prefectures and a comparison against all-Japan control
will be required. The results in our study indicate that
earwax type-determining SNP, rs17822931, in ABCC11
does not display a strong association with BC.
We also analyzed the association between ABCC11 genotype
and two subtypes (ER + and ER -) of human BC. The re-
sults revealed a correlation of earwax type with the BC sub-
type; patients with ER - tumors were less likely to be "AA"
homozygotes (Table 3). Moreover, risk per A-allele with an
OR of 0.54 (95% CI, 0.35-0.85, P=0.008) suggests that the
presence of mutant variant at rs17822931 may be important
for reducing the risk of development of ER - BC.
Our findings are somewhat contrast with a recent study
in which GA/GG genotypes (wet earwax type) were asso-
ciated with BC susceptibility in a Japanese population.14
Nevertheless, our results are supported by the widely ac-
cepted associations between ethnicity and BC characteris-
tics. Of note, it has been shown that BC mortality rates are
positively correlated with wet earwax type,13, 20 suggesting
that the higher rs17822931-A frequency in population, the
longer BC-specific survival is. Concordantly, women of Asian
ethnicity, and particularly Japanese Americans, the popula-
tion that carries rs17822931-A with a high frequency, are
more likely to develop ER +/progesterone receptor posi-
tive (PR+) subtype of BC.21 The lower mortality rates among
women of Asian ancestry is thus consistent with the idea
that patients with ER +/PR+ tumors have the lowest mor-
tality risk, compared to women with other BC subtypes.22
In the present study, we found an association of rs17822931-A
with decreased risk of ER - BC even analyzing the mini-
mally sufficient number of subjects. We believe that ex-
panding sample size of the Japanese BC patients will pro-
vide even stronger evidence for the association, and our
results may be expediently used for the future meta-analysis
of pooled data. At the same time, observation of a statisti-
cally significant correlation in Ukrainians or other European
populations is less feasible due to the low frequency of the
AA genotype among Caucasians.
In conclusion, our genotype analysis demonstrates that
the SNP determining earwax type is not a factor affecting
susceptibility to BC. However, AA genotype at rs17822931
occurs less frequently in ER - tumors, particularly in pa-
tients of Asian ancestry, leading to a notion that it may pos-
sibly play a protective role in carcinogenesis of this subtype
of BC.
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